P

Inventor

HOWLEY PAUL

AU47 patents
⚠️ This page may combine multiple inventors who share the name “HOWLEY PAUL”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

BAVARIAN NORDIC AS

26 patents
US7335364B2Feb 26, 2008

Modified Vaccinia Ankara virus variant

BAVARIAN NORDIC AS58 citations98
US6913752B2Jul 5, 2005

Modified Vaccinia Ankara virus variant

BAVARIAN NORDIC AS106 citations98
US6761893B2Jul 13, 2004

Modified vaccinia ankara virus variant

BAVARIAN NORDIC AS222 citations98
US7445924B2Nov 4, 2008

Modified Vaccinia Ankara virus variant and cultivation method

BAVARIAN NORDIC AS63 citations97
US7964398B2Jun 21, 2011

Modified vaccinia ankara virus variant and cultivation method

BAVARIAN NORDIC AS28 citations96
US7964395B2Jun 21, 2011

Modified vaccinia ankara virus variant and cultivation method

BAVARIAN NORDIC AS30 citations96
US7964396B2Jun 21, 2011

Modified vaccinia ankara virus variant and cultivation method

BAVARIAN NORDIC AS30 citations96
US7939086B2May 10, 2011

Modified Vaccinia Ankara virus variant

BAVARIAN NORDIC AS32 citations96
US7923017B2Apr 12, 2011

Modified Vaccinia Ankara virus variant

BAVARIAN NORDIC AS32 citations96
US7550147B2Jun 23, 2009

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

BAVARIAN NORDIC AS47 citations96
US7459270B2Dec 2, 2008

Modified Vaccinia Ankara virus variant

BAVARIAN NORDIC AS39 citations96
US7384644B2Jun 10, 2008

Modified Vaccinia Ankara virus variant

BAVARIAN NORDIC AS54 citations96
US7189536B2Mar 13, 2007

Modified vaccinia ankara virus variant

BAVARIAN NORDIC AS56 citations95
US8034354B2Oct 11, 2011

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

BAVARIAN NORDIC AS11 citations92
US8029800B2Oct 4, 2011

Recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)

BAVARIAN NORDIC AS12 citations92
US8021669B2Sep 20, 2011

Methods for inducing an immune response in a host comprising administering modified vaccinia virus ankara (MVA) recombinants comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)

BAVARIAN NORDIC AS21 citations92
US7964374B2Jun 21, 2011

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

BAVARIAN NORDIC AS13 citations92
US7501127B2Mar 10, 2009

Intergenic regions as novel sites for insertion of HIV DNA sequences in the genome of Modified Vaccinia virus Ankara

BAVARIAN NORDIC AS26 citations92
US7338662B2Mar 4, 2008

Recombinant poxvirus expressing homologous genes inserted into the foxviral genome

BAVARIAN NORDIC AS13 citations92
US6924137B2Aug 2, 2005

Method for virus propagation

BAVARIAN NORDIC AS20 citations90
US7569228B2Aug 4, 2009

Fusion proteins of non-attenuated HIV regulatory/accessory proteins

BAVARIAN NORDIC AS13 citations89
US7473536B2Jan 6, 2009

Isolated avian cell that expresses Vaccinia virus host range genes

BAVARIAN NORDIC AS9 citations84
US8741308B2Jun 3, 2014

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

BAVARIAN NORDIC AS3 citations74
US7759116B2Jul 20, 2010

MVA virus vector expressing dengue NS1 protein

BAVARIAN NORDIC AS7 citations71
US7094412B2Aug 22, 2006

Poxvirus containing formulations and process for preparing stable poxvirus containing compositions

BAVARIAN NORDIC AS9 citations71
US7300658B2Nov 27, 2007

Recombinant poxvirus comprising at least two compox ATI promoters

BAVARIAN NORDIC AS6 citations63

HOWLEY PAUL

15 patents
US8309098B2Nov 13, 2012

Recombinant modified vaccinia ankara (MVA) virus containing heterologous DNA inserts encoding human immunodeficiency virus (HIV) antigens inserted into one or more intergenic regions (IGRs)

HOWLEY PAUL33 citations96
US8435543B2May 7, 2013

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

HOWLEY PAUL8 citations92
US8414900B2Apr 9, 2013

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

HOWLEY PAUL8 citations92
US8309326B2Nov 13, 2012

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA)

HOWLEY PAUL8 citations92
US8288125B2Oct 16, 2012

Intergenic regions as insertion sites in the genome of modified vaccinia virus Ankara (MVA)

HOWLEY PAUL10 citations92
US8197822B2Jun 12, 2012

Method for the production of human immunodeficiency virus (HIV) proteins utilizing modified vaccinia virus ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)

HOWLEY PAUL6 citations84
US8143054B2Mar 27, 2012

Fusion protein of HIV regulatory/accessory proteins

HOWLEY PAUL7 citations84
US8323661B2Dec 4, 2012

Method for generating a stable recombinant modified vaccinia virus ankara (MVA) comprising human immunodeficiency virus (HIV) genes inserted into one or more intergenic regions (IGRs)

HOWLEY PAUL3 citations74
US8198088B2Jun 12, 2012

Method for introducing human immunodeficiency virus nucleotide sequences into a cell utilizing modified vaccinia virus Ankara (MVA) recombinants comprising HIV genes inserted into one or more intergenic regions (IGRs)

HOWLEY PAUL5 citations74
US8147839B2Apr 3, 2012

Fusion proteins of HIV regulatory/accessory proteins

HOWLEY PAUL2 citations63
US8137931B2Mar 20, 2012

Fusion proteins of HIV regulatory/accessory proteins

HOWLEY PAUL2 citations63
US8815501B2Aug 26, 2014

Flavivirus NS1 subunit vaccine

HOWLEY PAUL3 citations60
US9109233B2Aug 18, 2015

Recombinant poxvirus expressing homologous genes inserted

HOWLEY PAUL0 citations52
US8435535B2May 7, 2013

Fusion proteins of HIV regulatory/accessory proteins

HOWLEY PAUL0 citations52
US8389275B2Mar 5, 2013

Fusion proteins of HIV regulatory/accessory proteins

HOWLEY PAUL0 citations52

CHAPLIN PAUL

4 patents

SEMENTIS LTD

1 patent

VENTANA MED SYST INC

1 patent